Related Experiment Video
Updated: Oct 10, 2026

Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
Published on: June 3, 2014
The Factor VII mutation F7 c.760T>C (FVIIp.Cys254Arg) is causative for Factor VII deficiency by impairing secretion
Malte M Bartylla1, Sarah Cunningham1, Susanne Achenbach1
1Department of Transfusion Medicine and Hemostaseology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, 91054, Germany.
Background:
Hereditary Factor VII (FVII) deficiency is a bleeding disorder caused by mutations in the F7 gene, a diagnosis that is complicated by a weak genotype-phenotype correlation. However, accurate pathogenicity assessment of FVII variants is essential for effective clinical management.
Objectives:
Here, we report about the FVIIp.Cys254Arg variant, caused by the F7 c.760T>C mutation. This mutation was found in two patients, father and son, both presenting with FVII deficiency. We aimed to identify the molecular mechanism responsible for the underlying pathogenicity.
Methods:
Characterization of the FVIIp.Cys254Arg variant was performed using in silico analysis as well as an in vitro expression system. Subcellular localization and secretion of recombinant FVII protein were investigated using Western blotting, a bioluminescent protein quantification assay and confocal laser scanning microscopy.
Results:
The FVIIp.Cys254Arg variant results in the loss of a disulfide bond in the protease domain near the catalytic triad, which potentially destabilizes the tertiary protein structure. This leads to impaired secretion, as demonstrated in HEK293T cells and further supported by the FVII deficiency in the patients co-segregating with the mutation.
Conclusion:
The molecular analysis confirms the in silico prediction of the FVIIp.Cys254Arg variant as highly pathogenic and establishes this mutation as causative for hereditary FVII deficiency.
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
